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Abstract
Background: The effect of alcohol consumption on liver function is difficult to
determine because of reporting bias and potential residual confounding. Our aim
was to determine this effect using genetic variants to proxy for the unbiased effect
of alcohol.
Methods: We used variants in ADH1B and ADH1C genes as instrumental
variables (IV) to estimate the causal effect of long-term alcohol consumption on
alanine aminotransferase (ALT), c-glutamyl-transferase (c-GT), alkaline
phosphatase (ALP), bilirubin and prothrombin action. Analyses were undertaken on
58,313 Danes (mean age 56).
Results: In both confounder adjusted multivariable and genetic-IV analyses greater
alcohol consumption, amongst those who drank any alcohol, was associated with
higher ALT [mean difference per doubling of alcohol consumption: 3.4% (95% CI:
3.1, 3.7) from multivariable analyses and 3.7% (24.5, 11.9) from genetic-IV
analyses] and c-GT [8.2% (7.8, 8.5) and 6.8% (22.8, 16.5)]. The point estimates
from the two methods were very similar and statistically the results from the two
methods were consistent with each other for effects with ALT and c-GT (both
pdiff.0.3). Results from the multivariable analyses suggested a weak inverse
association of alcohol with ALP [21.5% (21.7, 21.3)], which differed from the
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strong positive effect found in genetic-IV analyses [11.6% (6.8, 16.4)] (pdiff,0.0001).
In both multivariable and genetic-IV analyses associations with bilirubin and
protrombin action were weak and close to the null.
Conclusions: Our results suggest that greater consumption of alcohol is related to
poorer liver function as indicated by higher ALT, c-GTand ALP, but not to clotting or
bilirubin.
Introduction
Alcoholic liver disease is a major global health problem, but the effects of lifetime
differences in alcohol consumption in the general population are unclear [1]. It
has been suggested that clinically apparent health damaging effects of
consumption occur at levels of 80 g/day of alcohol for 10–12 years [2], but there is
debate about whether lower levels also have adverse effects [3]. Most countries
recommend safe drinking levels of up to 30 g/day for men and 20 g/day for
women, but whether regular consumption at even these relatively low levels across
a substantial part of adult life might result in liver damage is unclear [4].
Examining the association of long-term alcohol consumption with outcomes
using conventional observational epidemiology methods is likely to be biased by:
(i) confounding by characteristics related both to alcohol consumption and liver
function/disease; (ii) ill health causing people to change their drinking behaviour
(so called ‘reverse causality’) and (iii) systematic mis-reporting, such that those
who are ill or are concerned about their drinking are likely to underreport intake
[2]. Randomised controlled trials of different levels of long-term consumption of
alcohol are not feasible. However, Mendelian randomization, in which genetic
variants that are robustly related to alcohol intake are used as instrumental
variables (IVs) to determine the life-time causal impact of different levels of
intake, could help address this question [5, 6]. Results from this method are
unlikely to be influenced by confounding or reverse causality [5, 7]. Simulation
studies suggest that systematic under-reporting of an exposure used in a
Mendelian randomization genetic-IV study can be biased away from the null [8].
However, since participants are extremely unlikely to know their genotype we
expect the magnitude of this bias to be less than that of the multiple regression
analysis, which would tend to bias results towards the null.
Alcohol is degraded to acetaldehyde in the liver by alcohol dehydrogenase and
then subsequently to acetate by acetaldehyde dehydrogenase [9]. Changes in this
degradation of alcohol that result in increased circulating and/or intracellular
acetaldehyde levels cause unpleasant nausea and flushing in relation to alcohol
consumption and as a consequence reduced levels of consumption [9]. In East
Asian populations a common variant in the ALDH2 gene, which encodes for
acetaldehyde dehydrogenase 2, has been associated with alcohol consumption
[10, 11]. Recent studies using this ALDH2 genotype suggest that lifetime alcohol
ADH1B and ADH1C, Alcohol and Liver Function
PLOS ONE | DOI:10.1371/journal.pone.0114294 December 15, 2014 2 / 14
consumption, in a dose response fashion across the distribution, is related to
higher ALT, AST and c-GT in East Asian populations [12–14]. However, since
this variant is not polymorphic in European populations it cannot be used to
examine the effects of alcohol on liver function or disease endpoints in Europeans.
Genetic variants in the alcohol dehydrogenase (ADH) genes also produce
between-person variation in the speed with which people degrade alcohol and its
metabolites, and consequently influence alcohol reactions and levels of
consumption [9, 15]. Amongst European origin populations, common functional
polymorphisms in ADH1B and ADH1C are associated with levels of alcohol
consumption; people who have fast degrading alleles consume less alcohol than
those with slow degrading alleles [15–17]. Whilst there is some evidence that these
variants are related to biomarkers of liver function and liver disease [18, 19], to
our knowledge no study has used these variants as IVs to explore the causal effect
of long-term alcohol consumption with liver outcomes.
The aim of this study was to use variants in ADH1B and ADH1C as genetic-IVs
to estimate the causal effect of long-term alcohol consumption on biomarkers of
liver function; alanine aminotransferase (ALT), c-glutamyl-transferase (c-GT),
alkaline phosphatase (ALP), bilirubin and prothrombin action (assessed as the
sum of action of coagulation factors II, VII and X, expressed as a percentage).
These biomarkers/enzymes are used in clinical practice to indicate problems with
liver function and the need for more invasive tests.
Methods
We used data from the Copenhagen General Population Study, a large general
population cohort study that aims to eventually recruit 100,000 participants and
collect genotypic and phenotypic data of relevance to a wide range of health
related problems. Individuals are randomly selected from the national Danish
Civil Registration System and have to be aged 20 years or older and resident in
greater Copenhagen; they also have to be white and of Danish decent.
Recruitment began in 2003 and is still on-going. Additional study details have
been previously published [6, 20, 21].
At the time of genotyping for the present study, 60,409 individuals had been
recruited; 60,383 (99.9%) of these had adequate data on both genotypes and
58,313 (96%) had complete data on genotype, alcohol consumption and all
potential confounding factors. These 58,313 provide our main analysis cohort.
The study outcomes are all blood-based measurements and for most outcomes
99.9% of the 58,313 main analysis cohort had adequate measurements. For
analyses with prothrombin action we removed the small number (1301/58,313,
2.2%) who had levels below 40% (indicating anticoagulation therapy) and so for
this outcome analyses are completed on 57,012 participants.
Participants provided informed written consent and the study was approved by
a Danish Medical Research Ethical Committee and by Herlev Hospital,
Copenhagen University Hospital.
ADH1B and ADH1C, Alcohol and Liver Function
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All measurements were completed by trained staff at one clinic centre. ALT, c-
GT, ALP, bilirubin and prothrombin action were measured using standard
hospital assays (Konelab and ACL) and were subject to daily internal quality
control assessing assay precision and monthly external quality control assessing
assay accuracy. The laboratory staff completing these assays were blind to all
participant characteristics, including age, gender, alcohol consumption, genotype
or any known illnesses.
Amount of usual alcohol intake was reported as weekly consumption of beer in
bottles and standard glasses of wine and spirits; each of these in Denmark contains
the equivalent of ,12 g of pure alcohol. Information on being a lifetime abstainer
or whether those reporting no consumption had previously drunk but then
stopped were not obtained and therefore those in the zero (no consumption)
category are a mixture of these two. The ADH1B (rs1229984, Arg47His in exon 3)
and ADH1C (rs698, Ile349Val in exon 8) genotypes were identified by TaqMan
assays described in the supplementary web-material (S1 File). Genotype calls
agreed with those using the Nanogen microelectronic chip technology [16, 22].
Details of how potential confounders were assessed have been reported in
previous publications [6, 16, 20, 21] and in the supplementary web-material (S1
File).
Statistical analyses
All analyses were conducted in Stata version 11. ALT, c-GT, ALP and bilirubin
were natural log-transformed to improve normality. An exact test was used to
examine Hardy-Weinberg Equilibrium (HWE) and linkage disequilibrium
between the two variants was assessed with Lewontin’s D’ and r2 [23, 24].
Our a priori assumption was that the genetic variants would not be associated
with potentially confounding factors of the alcohol-outcome associations, but we
checked this using linear or logistic regression.
We used two approaches to examine the relationship of alcohol with outcomes
- multivariable linear regression analyses and genetic-IV analyses, using ADH1B
and ADH1C genotypes as instruments. Both methods produce the regression
coefficients of liver function biomarkers on alcohol with the same units for both
methods. Assuming the underlying assumptions of each method are correct, they
both estimate the causal effect of alcohol consumption on each outcome. In
multivariable analyses we examined associations across the whole distribution of
alcohol consumption, including amongst those reporting no consumption, and
tested for departure from linearity (see additional analysis methods in S1 File).
Then in the main analyses we determined the graded dose response association of
alcohol consumption with liver function in those consuming some alcohol and
the mean difference in liver function between those who drank and those who
reported not drinking any alcohol using both the multivariable and genetic-IV
methods (the latter with ADH1B and ADH1C as IVs) and compared findings
using these two methods. Full details of how these analyses were completed,
ADH1B and ADH1C, Alcohol and Liver Function
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including underlying assumptions are provided in the supplementary web-
material (S1 File).
Results
The distributions of all characteristics were the same in the 60,383 eligible
participants and in the 58,313 participants with complete data who were included
in the analyses (S1 Table in S1 File). Overall, 10% of the population reported
drinking no alcohol and 9% reported drinking 25 or more drinks per week.
Drinking differed by gender, with 13% of women reporting no consumption and
3% reporting 25 or more drinks per week, compared with 6% of men reporting
no consumption and 17% reporting 25 or more drinks per week (p,0.0001).
Both genotypes were in HWE (p50.5 and 0.7 for ADH1B and ADH1C,
respectively). The linkage disequilibrium coefficient Lewontin’s D’ was 0.86 and r2
was 0.006 between ADH1B and ADH1C.
All of the observed confounders were associated with alcohol consumption (S2
Table in S1 File), but neither genotype was associated with any of the observed
confounding factors (Table 1).
Multivariable associations in all participants
Fig. 1 shows the fully-adjusted associations of alcohol category with outcomes.
Detailed age and gender (S3 Table in S1 File) and fully adjusted (S4 Table in S1
File) associations with all outcomes by alcohol category are shown in
supplementary web material. In these analyses (that included all participants,
including non-drinkers) alcohol consumption was positively associated with ALT,
c-GT, bilirubin and prothrombin action. There was also a weak inverse
association with ALP (i.e. suggesting higher alcohol consumption is associated
with lower ALP). Because of the large sample size for these observational analyses,
p-values for linear trend and also for deviation from linearity are small. Amongst
those drinking some alcohol, positive associations for ALT, c-GT and inverse
associations for ALP are monotonic. Fig. 1 has the same scale for each outcome
on the Y-axis and it can be seen from this, that despite all associations having very
low p-values, the magnitude of the linear association in these multivariable
analyses is weak/modest for all except ALT and c-GT.
Genetic-instrumental variable effects and their comparison with
multivariable associations
Individuals with greater numbers of fast degrading alleles were more likely to be
non-drinkers and on average drank less alcohol if they reported some
consumption (Fig. 2 and Table 2). These associations are monotonic, but the
difference between those with 3 or 4 alleles is greater than those between 0 and 1
or 1 and 2. Associations of ADH1B, ADH1C and the total allele score with alcohol
consumption were similar in males and females (S5a Table in S1 File; pinteraction
ADH1B and ADH1C, Alcohol and Liver Function
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all $0.3). Genotypes appeared more strongly related to alcohol consumption at
younger compared with older ages (S5b Table in S1 File), but there was no strong
statistical evidence that associations differed by age (pinteraction all $0.1).
The overidentification test results for all analyses provided evidence that the
two SNPs are providing consistent IV results and are jointly valid instruments for
alcohol consumption (poveridentification$0.2). Associations using different IV
Table 1. Associations of observed confounders with ADH1B and ADH1C genotype.
ADH1B ADH1C
Mean (SD) or N (%) by genotype Mean (SD) or N (%) by genotype
1/1 (slow)
N555,880
1/2 or 2/2
(fast) N52433 p-valuea
2/2 (slow)
N510,155
1/2 (intermediate)
N528,415
1/1 (fast)
N519,743 p-valuea
Age (years) 56.6 (13.4) 57.1 (13.3) 0.13 56.6 (13.3) 56.7 (13.3) 56.6 (13.4) 0.55
Women (n, %) 31,144 (56) 1,324 (54) 0.20 5,741 (56) 15,818 (56) 10,909 (55) 0.11
Current smoker (n, %) 11,813 (21) 514 (21) 0.99 2,221 (22) 5,957 (21) 4,149 (21) 0.14
.4 hours per week MVPA 26,871 (48) 1,194 (49) 0.34 4,898 (48) 13,662(48) 9,505 (48) 0.96
Income .600,000Kr 10,767 (19) 499 (20) 0.13 1,946 (19) 5,535 (19) 3,785 (19) 0.64
Education .13 years 9,425(17) 416 (17) 0.76 1,776 (17) 4,738 (17) 3,327 (17) 0.17
N558,313.
aF-statistic for continuous variables and chi-square for categorical variables testing the null hypothesis that distributions of the confounders do not differ by
genotype (1 degree of freedom for ADH1B and 2 degrees of freedom for ADH1C).
MVPA5Moderate or vigorous physical activity. Kr5Danish kroner.
doi:10.1371/journal.pone.0114294.t001
Fig. 1. Multivariable associations of alcohol consumption with biomarkers of liver function. N558,313.
All associations are adjusted for age, gender, physical activity, smoking, education and income. The reference
category in all analyses is no drinks; this takes the null value of 0 for all outcomes.
doi:10.1371/journal.pone.0114294.g001
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Fig. 2. Association of combined ADH1B and ADH1B fast-allele score with alcohol consumption.
N558,313. Shows geometric means (dots) and 95% confidence intervals of geometric means (vertical lines)
of alcohol grams per week in those consuming some alcohol (A) and prevalence (%) (dots) and 95%
confidence intervals of non-drinkers in the whole cohort (B) by total number of fast-alleles.
doi:10.1371/journal.pone.0114294.g002
Table 2. Association of ADH1B and ADH1C with alcohol consumption.
Mean difference (%) alcohol consumption in
those consuming some alcohol (95% CI) N552,559
OR of being a non-drinker in the
whole cohort (95% CI) N558,313
ADH1B one or two fast alleles versus none –15.8 (–19.9, 211.8) 1.45 (1.28, 1.63)
R2 0.0011
F-test 59 37a
P-value ,0.0001 ,0.0001
ADH1C per fast allele –2.2 (–3.3, 21.0) 1.06 (1.02, 1.10)
R2 0.0001
F-test 14 9a
P-value 0.0002 0.003
Total ADH1B plus ADH1C allele score –3.0 (–4.1, 21.9) 1.09 (1.05, 1.13)
R2 0.0012
F-test 31 20a
P-value ,0.0001 ,0.0001
OR: Odds ratio; CI: confidence intervals.
aFrom a model of the mean risk difference of not drinking.
doi:10.1371/journal.pone.0114294.t002
ADH1B and ADH1C, Alcohol and Liver Function
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analysis methods (S6 Table in S1 File) were similar to the main analyses using the
control function.
In both confounder adjusted multivariable and genetic-IV analyses greater
alcohol consumption, amongst those who drank any alcohol, was associated with
higher ALT and c-GT (Table 3). Whilst the sizes of the associations for the two
analytical methods for these two outcomes were similar, with ALT increasing by
3–4% per doubling of alcohol intake and c-GT by 7–8% per doubling of intake,
the confidence intervals around the genetic-IV analysis results were very wide and
included the null value. The weak (21.5%) inverse association of alcohol with
ALP in the multivariable analyses was in stark contrast to the positive association
in the genetic-IV analyses (mean difference 11.6% (95% CI: 6.8, 16.4) per
doubling of alcohol intake amongst those drinking some alcohol) and there was
statistical evidence that these results differed from each other (pdifference,0.001).
In both multivariable and genetic-IV analyses associations with bilirubin and
prothrombin action were weak and close to the null, being weakly positive in
multivariable and null in genetic-IV analyses.
Table 4 shows the multivariable and genetic-IV analysis results comparing
drinkers to non-drinkers. These results were broadly consistent with those
examining associations of amount of consumption amongst drinkers, such that
drinkers (of any amount) compared to non-drinkers had higher ALT and c-GT in
both multivariable and IV analyses, but with the latter being imprecisely
estimated. There was a marked difference between the multivariable and IV
analyses for ALP with the multivariable analyses suggesting a slightly lower level in
drinkers but the genetic-IV analyses a marked higher level in drinkers compared
to drinkers.
Additional results
In the multivariable confounder adjusted analyses there was statistical evidence
that associations differed between males and females for ALT, c-GT and
prothrombin action. For prothrombin action the point estimates were similar in
males and females but because of the large sample size in this study it was possible
to have small p-values even for small differences that would not be of clinical
importance (S7 Table in S1 File). In the genetic-IV analyses there was no
statistical evidence that associations differed by gender for any outcome and, for
most, point estimates were very similar to each other (S7 Table in S1 File).
However, the positive effect of alcohol on ALT was stronger in males compared to
females in the genetic-IV analyses, as seen in the multivariable analyses (S7 Table
in S1 File). There was no evidence that associations differed by age for either
multivariable or genetic-IV analyses, and when analyses were repeated with the
youngest age group (20–39 years) removed they were essentially the same as those
presented in Tables 3 and 4.
The median (interquartile range) percentage contribution to total alcohol
consumed was 69% (47, 92), 18% (0, 40) and 0% (0, 14) for wine, beer and
spirits, respectively. The Spearman correlation coefficients for amount consumed
ADH1B and ADH1C, Alcohol and Liver Function
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between total alcohol and each of wine, beer and spirits were 0.83, 0.60 and 0.50,
respectively (all p-values,0.00001). The pattern of association of ADH1B and
ADH1C with wine and beer was similar to that with total alcohol consumption
(S1a and S1b Figures in S1 File). Variants did not appear to be associated with
amount of spirits consumed (S1c Figure in S1 File). Both the multivariable and
IV analyses results were similar when either wine or beer were used instead of total
alcohol (results available from authors on request). The multivariable analyses
with amount of spirits consumed were similar to those with total alcohol (results
available from authors), but since there was no association of variants with spirits
we were not able to undertake IV analysis with this exposure.
Associations of ADH1B with observed confounders were similar amongst
drinkers and non-drinkers, with the exception of smoking (S8 Table in S1 File).
There was no strong statistical evidence of an interaction between ADH1B and
alcohol consumption (none versus some) in their associations with any outcomes
(S8 Table in S1 File).
Table 3. Confounder adjusted multivariable and instrumental variable associations of alcohol with biomarkers of liver function in those who report some
alcohol consumption (i.e. those reporting no consumption have been removed from these analyses).
Mean difference in each outcome per doubling of alcohol (95% CI)
ALT (%)
N552,518
c-GT (%)
N552,522
ALP (%)
N552,521
Bilirubin (%)
N552,521
Prothrombin (%)
N551,400
Multivariable 3.4 (3,1, 3.7) 8.2 (7.8, 8.5) –1.5 (–1.7, 21.3) 1.1 (0.8, 1.3) 0.8 (0.7, 0.9)
Instrumental variable 3.7 (–4.5, 11.9) 6.8 (–2.8, 16.5) 11.6 (6.8, 16.4) –2.4 (–9.4, 4.7) –1.8 (–5.3, 1.7)
Pdifference instrumental
variable vs. multivariablea
0.53 0.37 ,0.0001 0.13 0.24
CI: confidence interval; ALT: alanine aminotransferase; c-GT: c-glutamyl-transferase; ALP: alkaline phosphatase; Prothrombin: Prothrombin action.
In the multivariable analysis all results are adjusted for age, gender, smoking, physical activity, education and income.
In the instrumental variable analysis the control function method was used with ADH1B and ADH1C used jointly as categorical (indicator) instrumental
variables. The first stage F-statistic for all instrumental variable analyses534.
aTest of null hypothesis that there is no difference in association of alcohol with each outcome between the confounder adjusted multivariable association
(row 1) and the instrumental variable association using the control function (row 2); p-value obtained from the bootstrap distribution.
doi:10.1371/journal.pone.0114294.t003
Table 4. Confounder adjusted multivariable and instrumental variable associations of drinking versus not drinking alcohol with biomarkers for liver function.
Mean difference in each outcome comparing drinkers non-drinkers (95% CI)
ALT (%)
N558,265
c-GT (%)
N558,270
ALP (%)
N558,271
Bilirubin (%)
N558,271
Prothrombin (%)
N557,012
Multivariable 4.2 (2.9, 5.4) 9.5 (8.0, 11.0) –6.1 (–6.9, 25.4) 3.4 (2.3, 4.4) 0.5 (0.0, 1.1)
Instrumental variable 28.1 (–19.0, 75.2) 57.8 (2.3, 113.3) 53.6 (26.1, 81.0) 0.4 (–39.5, 40.3) –14.7 (–34.8, 5.4)
Pdifference instrumental
variable vs. multivariablea
0.44 0.11 ,0.0001 0.61 0.22
CI: confidence interval; ALT: alanine aminotransferase; c-GT: c-glutamyl-transferase; ALP: alkaline phosphatase; Prothrombin: Prothrombin action.
In the multivariable analysis all results are adjusted for age, gender, smoking, physical activity, education and income.
In the instrumental variable analysis the control function method was used with ADH1B and ADH1C used jointly as categorical (indicator) instrumental
variables. The first stage F-statistic for all instrumental variable analyses521.
aTest of null hypothesis that there is no difference in association of alcohol with each outcome between the confounder adjusted multivariable association
(row 1) and the instrumental variable association using the control function (row 2); p-value obtained from the bootstrap distribution.
doi:10.1371/journal.pone.0114294.t004
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Discussion
In this large study we used genetic variants that are related to alcohol
consumption as genetic-IVs to determine the effect of long-term alcohol intake on
liver function. Our results show a monotonic association of greater alcohol
consumption amongst those drinking some alcohol with higher ALT and c-GT in
multivariable analyses after controlling for observed confounders. The results
from our genetic-IV analyses had very similar point estimates and were
statistically consistent for these two outcomes. However, the confidence intervals
of the genetic-IV estimates were wide and included the null value. Similar findings
were obtained comparing drinkers (of any amount) to non-drinkers. Taken
together these results suggest that incrementally greater long-term alcohol
consumption (across its distribution) is causally related to poorer liver function as
indicated by these two biomarkers.
For ALP, multivariable analyses suggested a weak inverse association whereas
the genetic-IV analyses suggested a strong positive association (more alcohol
consumption higher levels of ALP) and there was statistical evidence that results
from these two methods differed from each other for this outcome. Elevated levels
of ALP would be expected with hepatic or biliary dysfunction and so the positive
association with alcohol seen in the genetic-IV analyses is more plausible than the
inverse association in the multivariable analyses. ALP is not specific to the
hepatobiliary system and circulating levels are also affected by bone turnover and
a range of nutritional factors. Levels are reduced in the presence of low protein
malnutrition and other nutrient deficiencies, including vitamin B6 and C, which
are common with excessive alcohol consumption. Thus, it is possible that the
weak inverse association in the multivariable analyses is due to confounding by
lack of self-care, reflected in sedentary behaviour (and hence low bone turnover)
and poor nutrition, which are associated with greater alcohol consumption and
lower ALP. Such confounding is unlikely to bias the IV analysis results [5, 7]. As
noted in the introduction, misclassification of alcohol consumption by
participants who are ill or concerned about their alcohol consumption would tend
to bias the multiple regression analyses towards the null and the genetic-IV
analyses away from the null. However, it seems unlikely that these biases would
produce a marked difference in ALP results, whereas for all of the other markers
of liver function that we have assessed, results are consistent with each other for
the two methods.
The stronger association of alcohol with ALT in men than women in both the
multivariable and genetic-IV analyses may reflect real differences in their response
to alcohol, but studies generally suggest women have more adverse effects to
alcohol than do men [25, 26]. These differences could be chance findings and
require further replication.
Recent studies in East Asian populations have used a Mendelian randomization
approach, but with variants in those populations that have stronger associations
with alcohol, and found strong evidence for dose-response effects of lifetime
alcohol consumption on markers of liver function (ALT, AST and c-GT) [12–14].
ADH1B and ADH1C, Alcohol and Liver Function
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In two recent meta-analyses, including Asian, European, African and Native
American populations, the variants that we have used as genetic-IVs in this study,
were shown to have strong associations with a combined outcome of alcohol-
dependency, abuse and poorer liver function [18, 19]. It is difficult to compare the
findings from those studies with ours because of the combined outcome and the
lack of a formal IV analyses testing the association of alcohol consumption with
liver function. However, the associations were strongest in Asian populations and
did not reach conventional levels of statistical significance in European
populations, which may have reflected lack of statistical power given the
considerably lower prevalence of the minor alleles in these populations.
We examined associations with different markers of liver function and where
these are on the same scale have found some differences in the magnitude of
effect. c-GT is regarded as a useful biomarker for alcohol consumption and our
results suggest alcohol has a stronger causal effect on c-GT than ALT. The weak
multivariable, and null genetic-IV, association of alcohol with bilirubin and
prothrombin suggests that for these more severe markers of liver damage there
might not be a continuous dose-response effect of alcohol, but possibly a
threshold or multi-stage effect. Though, this would need further exploration.
We examined IV assumptions [5] and tried to reduce violation of these as
much as possible in this study. Whilst alcohol consumption was associated with
all of the measured confounders, the two genetic variants were not associated with
any, suggesting the assumption that the genetic-IV is not related to confounders is
plausible. Since this cohort consisted of white individuals of Danish descent,
population stratification is unlikely, this is further supported by the lack of
association of these variants with height (Table 1). It is conceivable that in social
groups where there is pressure to consume alcohol any effect of the genetic
variants will be over-ridden by this social pressure. However, we have shown that
in the youngest age group (20–39 years), amongst whom this pressure might be
greatest, the variants are if anything more strongly associated with consumption
than at older ages. In our study the association of ADH fast alleles with alcohol,
when both variants were simply summed together, appears to be largely driven by
the difference in alcohol consumption between those with 3 or 4 alleles compared
with all other individuals. However, our main results combined the two variants
as separate categorical variables and these results were consistent with those from
a weighted allele score IV (results in S1 File). Our results were also robust to
different IV analysis methods. For all analyses the first-stage F-statistic did not
suggest we had problems with weak instrument bias, though the genetic-IV
analysis results were imprecisely estimated with wide confidence intervals. With
the exception of ALT, discussed above, the results for all other markers of liver
function were consistent with each other. Since the two approaches have differing
sources of bias, this consistency further strengthens the likelihood that these
results reflect the causal effect.
A key limitation is our inability to distinguish between lifetime abstainers and
those who have stopped drinking because of ill-health amongst the non-drinkers.
This would potentially bias the multivariable analyses more so than the genetic-IV
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analyses, but could result in some underestimation of true associations in both.
Since the genetic variants can only affect amount of alcohol consumed amongst
those who have tried drinking some alcohol, we would not expect them to be
related to liver outcomes in those who have never consumed alcohol (see further
discussion in S1 File) [27]. In our study we found no evidence of statistical
interaction between ADH1B and alcohol consumption with outcomes (S1 File).
This could be because the group who (at the time of recruitment) report that they
do not drink alcohol includes many who had been heavy drinkers and stopped
drinking because of alcohol related ill-health or it could be that we lack statistical
power to detect an interaction between ADH1B and alcohol consumption. One
study in Japanese men found that variants in the ALDH2 genotype were more
strongly associated with AST, ALT and c-GT amongst heavy alcohol drinkers than
in low level drinkers, with those reporting moderate levels of consumption having
associations between these two [14]. However, the sample size in that study was
small (N5385) and we are not aware of any other studies that have explored the
interactions we have examined in European populations.
A further limitation is our inability to examine associations with liver disease
outcomes. This was because the prevalence of these in this cohort, based on
hospital admissions or death certifications is low, with just 0.7% having evidence
of any alcohol-related liver disease, and with most of these already being present at
recruitment (only 0.2% had incident alcoholic liver disease or death). To our
knowledge no other study has used a Mendelian randomization approach to
examine long-term alcohol consumption with such hard outcomes. We have
examined associations with a range of liver function markers that reflect different
aspects of liver function but have not been able to include all markers of liver
function. In particular AST has not been measured in this cohort. In general AST
and ALT respond similarly to liver damage and disease, though AST may increase
by a greater amount in response to alcohol excess.
To conclude, we have used genetic variants that are robustly associated with
alcohol consumption as IVs to examine the causal effect of alcohol consumption
on liver function. Our findings suggest that greater long-term alcohol
consumption had a graded linear associated with more adverse liver enzyme levels
in a dose response way. The magnitudes of the point estimate of cause effect from
the Mendelian randomization analyses suggest quite a large effect. However, the
confidence intervals are wide and often include the null value. This is because even
with both variants used together, they explain only a small proportion of the
variation in alcohol consumption and much larger Mendelian randomization
studies would be required to obtain precise estimates from this method. We are
not aware of any studies with such large samples sizes and relevant data. Of note
for most of the markers assessed there is close similarity in the magnitude of
associations between the confounder adjusted multivariable and the genetic-IV
analyses, which given their different sources of bias, provides support for these
estimates representing the magnitude of causal effect. These findings need further
replication in larger samples.
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